Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is now a range of genome- and epigenome-editing techniques (reviewed by Pamies et al., 2018), as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concept of Good Cell Culture Practice (GCCP) (Coecke et al., 2005) was developed and gradually adapted to ongoing scientific progress (Pamies et al., 2018) as a guidance document for in vitro reporting standards.”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“GCCP 2.0 is trying to complement these for stem cell-derived models and microphysiological systems (MPS).”
From Toward good in vitro reporting standards (2019) · cites this paper as Pamies et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Complementarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Pamies et al. 2018
The cited source says what the claim attributes to it.
In the citing paper
“This is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known (Pamies et al., 2018).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct
Pereira, R., Martin, M., Roussel, A., Carribault, P., & Gautier, T. (2023) · Lecture Notes in Computer Science · doi:10.1007/978-3-031-40744-4_5 · Cited by 12,935
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Research works printed but not linked: 1
- altex1406111 · doi:10.14573/altex1406111 · Paper page
Cited by
Evidence-based Guidelines for Controlling pH in Mammalian Live-Cell Culture Systems
Michl, J., Park, K. C., & Swietach, P. (2019) · Communications Biology · doi:10.1038/s42003-019-0393-7 · Cited by 267
In Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“…form of workshops and supporting guidance documents, such as the OECD Guidance Document (GD) on Good In Vitro Method Practices (OECD, 2018), a recommendation on reporting standards (Hartung et al., 2019) and a Good Cell Culture Practice (GCCP) document for iPSC and MPS (Pamies et al., 2017, 2018).”
BackgroundIn Vitro research Reproducibility: Keeping up High Standards
Hirsch, C., & Schildknecht, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01484 · Cited by 161
Escher, S. E., Kamp, H., Bennekou, S. H., Bitsch, A., Fisher, C., Graepel, R., Hengstler, J. G., Herzler, M., Knight, D. J., Leist, M., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02591-7 · Cited by 166
Standardisation needs for organ on chip devices
Piergiovanni, M., Leite, S. B., Corvi, R., & Whelan, M. (2021) · Lab on a Chip · doi:10.1039/d1lc00241d · Cited by 155
Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X. (2020) · Micromachines · doi:10.3390/mi11040381 · Cited by 140
“With the rapid recognition of this issue, people began to discuss good cell culture practice (GCCP) [147] to establish cell quality standards and ensure the integrity and reproducibility of multi-organ chips in vitro.”
BackgroundEmerging technologies and their impact on regulatory science
Anklam, E., Bahl, M. I., Ball, R., Beger, R. D., Cohen, J. E., Fitzpatrick, S., Girard, P., Halamoda‐Kenzaoui, B., Hinton, D., Hirose, A., et al. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211052280 · Cited by 148
Rovida, C., Barton-Maclaren, T., Benfenati, E., Caloni, F., Chandrasekera, P. C., Chesné, C., Cronin, M. T. D., Knecht, J. D., Dietrich, D. R., Escher, S. E., et al. (2020) · ALTEX · doi:10.14573/altex.1912181 · Cited by 122
“Books such as by Cronin et al. (2013) provide a sound basis to the theory, and recent papers such as Patlewicz et al. (2017, 2018, 2019) include updates on the tools that may be applied.”
MethodThe exposome – a new approach for risk assessment
Sillé, F. C. M., Karakitsios, S., Kleensang, A., Koehler, K., Maertens, A., Miller, G. W., Prasse, C., Quirós-Alcalá, L., Ramachandran, G., Rappaport, S. M., et al. (2020) · ALTEX · doi:10.14573/altex.2001051 · Cited by 109
“This means that the QA aspects of in vitro work (Hartung, 2007; Pamies and Hartung, 2017; Pamies et al., 2017, 2018) and their reporting (Hartung et al., 2019; Krebs et al., 2019) apply also to exposomics.”
Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100
“…and a Steering Committee and Scientific Advisory Committee were formed under the auspices of the Center for Alternatives to Animal Testing (CAAT) (Pamies et al., 2017, 2018; Eskes et al., 2017) to consider the advances in “-omics” technology, stem cell research, and cell and tissue culture…”
BackgroundInfluentialSelf-citationvan der Velden, J., Asselbergs, F. W., Bakkers, J., Bátkai, S., Bertrand, L., Bezzina, C. R., Bot, I., Brundel, B. J. J. M., Carrier, L., Chamuleau, S. A. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab370 · Cited by 105
Cell culture‐derived extracellular vesicles: Considerations for reporting cell culturing parameters
Shekari, F., Alibhai, F. J., Baharvand, H., Börger, V., Bruno, S., Davies, O. G., Giebel, B., Gimona, M., Salekdeh, G. H., Jaular, L. M., et al. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.115 · Cited by 106
“There are several guidelines on good practices for general cell and tissue culture for cellular therapy (Coecke et al., 2005; Pamies, 2018; Pamies et al., 2017).”
BackgroundTranslational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption
Allwardt, V., Ainscough, A. J., Viswanathan, P., Sherrod, S. D., McLean, J. A., Haddrick, M., & Pensabene, V. (2020) · Bioengineering · doi:10.3390/bioengineering7030112 · Cited by 88
Cellular expansion of MSCs : Shifting the regenerative potential
Miclau, K. R., Hambright, W. S., Huard, J., Stoddart, M. J., & Bahney, C. S. (2022) · Aging Cell · doi:10.1111/acel.13759 · Cited by 97
Necrotizing enterocolitis induces T lymphocyte–mediated injury in the developing mammalian brain
Zhou, Q., Niño, D. F., Yamaguchi, Y., Wang, S., Fulton, W. B., Jia, H., Lu, P., Prindle, T., Pamies, D., Morris, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay6621 · Cited by 94
Self-citationPamies, D., Ekert, J., Zurich, M.-G., Frey, O., Werner, S., Piergiovanni, M., Freedman, B. S., Keong Teo, A. K., Erfurth, H., Reyes, D. R., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.03.009 · Cited by 88
Self-citation3S - Systematic, systemic, and systems biology and toxicology
Smirnova, L. (2018) · ALTEX · doi:10.14573/altex.1804051 · Cited by 72
“The concomitant emerging availability of human stem cells that can be used to produce high-quality organoids further adds to this revolutionary change (Suter-Dick et al., 2015), as shown recently for the BrainSphere organoid model (Pamies et al., 2017a, 2018a).”
BackgroundInfluentialhttps://www.altex.org/index.php/altex/article/view/1339
Krebs, A., Waldmann, T., Wilks, M. F., van Vugt-Lussenburg, B. M. A., van der Burg, B., Terron, A., Steger-Hartmann, T., Ruegg, J., Rovida, C., Pedersen, E., et al. (2019) · ALTEX · doi:10.14573/altex.1909271 · Cited by 77
Optimizing drug discovery by Investigative Toxicology: Current and future trends
Beilmann, M., Boonen, H., Czich, A., Dear, G., Hewitt, P., Mow, T., Newham, P., Oinonen, T., Pognan, F., Roth, A., et al. (2018) · ALTEX · doi:10.14573/altex.1808181 · Cited by 86
Toward good in vitro reporting standards
Hartung, T. (2019) · ALTEX · doi:10.14573/altex.1812191 · Cited by 65
“…Good Cell Culture Practices (GCCP) (Coecke et al., 2005), which are currently being expanded to incorporate organotypic cultures, including microphysiological systems, as GCCP 2.0 (Pamies et al., 2017a, 2018; Pamies and Hartung, 2017) define minimum standards for cell culture and its documentation.”
InfluentialAinslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M. (2019) · Lab on a Chip · doi:10.1039/c9lc00492k · Cited by 65
Organ-on-a-chip technology: turning its potential for clinical benefit into reality
Haddrick, M., & Simpson, P. B. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.011 · Cited by 63
Bas, A., Burns, N., Gulotta, A., Junker, J., Drasler, B., Lehner, R., Aicher, L., Constant, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Small · doi:10.1002/smll.202006027 · Cited by 60
Lehmann, M., Krishnan, R., Sucre, J. M. S., Kulkarni, H. S., Pineda, R., Anderson, C., Banovich, N. E., Behrsing, H. P., Dean, C. H., Haak, A. J., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0479st · Cited by 60
Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres Are Suitable for Neurotoxicity Screening
Kobolak, J., Teglasi, A., Bellak, T., Janstova, Z., Molnar, K., Zana, M., Bock, I., Laszlo, L., & Dinnyes, A. (2020) · Cells · doi:10.3390/cells9051122 · Cited by 53
Appelt‐Menzel, A., Oerter, S., Mathew, S., Haferkamp, U., Hartmann, C., Jung, M., Neuhaus, W., & Pleß, O. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.122 · Cited by 57
Krebs, A., van Vugt-Lussenburg, B. M. A., Waldmann, T., Albrecht, W., Boei, J., ter Braak, B., Brajnik, M., Braunbeck, T., Brecklinghaus, T., Busquet, F., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02802-6 · Cited by 48
Ribeiro, A. J. S., Guth, B. D., Engwall, M. J., Eldridge, S. R., Foley, C. M., Guo, L., Gintant, G. A., Koerner, J. E., Parish, S. T., Pierson, J. B., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00934 · Cited by 58
Applicability of organ-on-chip systems in toxicology and pharmacology
Schneider, M. R., Oelgeschläger, M., Burgdorf, T., van Meer, P. J. K., Theunissen, P. T., Kienhuis, A. S., Piersma, A. H., & Vandebriel, R. J. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1953439 · Cited by 53
Moreira, A., Müller, M., Costa, P. F., & Kohl, Y. (2021) · Advanced Biology · doi:10.1002/adbi.202101139 · Cited by 52
Fritsche, E., Barenys, M., Klose, J., Masjosthusmann, S., Nimtz, L., Schmuck, M., Wuttke, S., & Tigges, J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy178 · Cited by 49
Organoid intelligence (OI) – The ultimate functionality of a brain microphysiological system
Smirnova, L., Pantoja, I. E. M., & Hartung, T. (2023) · ALTEX · doi:10.14573/altex.2303261 · Cited by 52
A call for a Human Exposome Project
Härtung, T. (2023) · ALTEX · doi:10.14573/altex.2301061 · Cited by 44
Spînu, N., Cronin, M. T. D., Lao, J., Bal-Price, A., Campia, I., Enoch, S. J., Madden, J. C., Mora Lagares, L., Novič, M., Pamies, D., et al. (2022) · Computational Toxicology · doi:10.1016/j.comtox.2021.100206 · Cited by 36
Self-citationPamies, D. (2020) · ALTEX · doi:10.14573/altex.2007091 · Cited by 35
Self-citationApplication of Microelectrode Array Approaches to Neurotoxicity Testing and Screening
Shafer, T. J. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-11135-9_12 · Cited by 43
In vitro to in vivo translation
Mattes, W. B. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.09.001 · Cited by 41
Punt, A., Louisse, J., Pinckaers, N. E. T., Fabian, E. J., & van Ravenzwaay, B. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab150 · Cited by 38
“…rat; PBPK; PBK. Substantial advances have been made over the last decades with the development of in vitro methods to capture biological effects of compounds that may serve as alternative test methods for animal toxicity testing (Jennings, 2015; Pamies et al., 2018; Pamies and Hartung, 2017).”
Human mini-blood–brain barrier models for biomedical neuroscience research: a review
Tran, M., Heo, C., Lee, L. P., & Cho, H. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00332-z · Cited by 34
“However, this cell line is incapable of self-renewal, resulting in senescent functional and morphological alterations [49, 50].”
BackgroundRomero, J. C., Berlinicke, C. A., Chow, S., Duan, Y., Wang, Y., Chamling, X., & Smirnova, L. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1094291 · Cited by 39
Sillé, F. C. M., Busquet, F., Fitzpatrick, S., Herrmann, K., Leenhouts-Martin, L., Luechtefeld, T., Maertens, A., Miller, G. W., Smirnova, L., Tsaioun, K., et al. (2024) · ALTEX · doi:10.14573/altex.2407081 · Cited by 35
Hoyle, H. W., Stenger, C. M. L., & Przyborski, S. A. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100063 · Cited by 36
Polit, L. D., Eidhof, I., McNeill, R. V., Warre-Cornish, K. M., Ohki, C. M. Y., Walter, N. M., Sala, C., Verpelli, C., Radtke, F., Galderisi, S., et al. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101125 · Cited by 35
“Excellent reviews have been published on topics such as Good Cell Culture Practice (GCCP) (Pamies et al., 2018, 2022); generation of hiPSCs, including Good Manufacturing Practice (GMP) grade cells (Abranches et al., 2020); as well as guidelines and recommendations for biobanking and molecular and genetic studies using…”
Krebs, A. (2020) · ALTEX · doi:10.14573/altex.1909271e · Cited by 31
Advancements in Organoid‐Based Drug Discovery: Revolutionizing Precision Medicine and Pharmacology
Singh, D., Thakur, A., Rakesh, & Kumar, A. A. (2025) · Drug Development Research · doi:10.1002/ddr.70121 · Cited by 30
Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity
Chesnut, M., Hartung, T., Hogberg, H., & Pamies, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157929 · Cited by 29
Self-citationKandilogiannakis, L., Filidou, E., Drygiannakis, I., Tarapatzi, G., Didaskalou, S., Koffa, M. D., Arvanitidis, K. I., Bamias, G., Valatas, V., Paspaliaris, V., et al. (2021) · Stem Cells International · doi:10.1155/2021/9929461 · Cited by 28
“Secondly, organoids can reduce the need for 2D cultures of primary cells; in most cases, they are difficult to isolate, characterize, and maintain in culture for prolonged periods of time [24].”
BackgroundSeeger, B. (2020) · Alternatives to Laboratory Animals · doi:10.1177/0261192920974026 · Cited by 28
“In addition, the standardisation of essential stem cell culture media should be facilitated by avoiding the use of any animal-derived biological materials such as fetal bovine serum.(119) When pluripotent stem cells are differentiated over long periods (i.”
BackgroundPintacuda, G., Martín, J. M., & Eggan, K. C. (2021) · Molecular Autism · doi:10.1186/s13229-021-00417-x · Cited by 27
Ma, C., Seong, H., Li, X., Yu, X., Xu, S., & Li, Y. (2022) · Stem Cells International · doi:10.1155/2022/2150680 · Cited by 30
Organ-on-a-Chip: Ubi sumus? Fundamentals and Design Aspects
Morais, A. S., Mendes, M., Cordeiro, M. A., Sousa, J., Pais, A. A. C. C., Mihaila, S. M., & Vitorino, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050615 · Cited by 26
“These cell lines hold potential for disease modeling and personalized drug screening studies, offering an alternative to costly and invasive primary tissue isolation procedures [108].”
BackgroundBone microphysiological models for biomedical research
Verdugo-Avello, F., Wychowaniec, J. K., Villacis-Aguirre, C. A., D’Este, M., & Toledo, J. R. (2025) · Lab on a Chip · doi:10.1039/d4lc00762j · Cited by 25
A path forward advancing microphysiological systems
Härtung, T., & Smirnova, L. (2025) · ALTEX · doi:10.14573/altex.2504091 · Cited by 43
“2), starting with workshops on 3D cell culture (Alé-pée et al., 2014), investigative toxicology (Beilmann et al., 2019), and parallel work on the expansion of Good Cell Culture Practice to MPS (Pamies et al., 2017b, 2018, 2020a, 2022).”
Ribeiro, M. C., Rivera‐Arbeláez, J. M., Cofiño‐Fabrés, C., Schwach, V., Slaats, R. H., ten Den, S. A., Vermeul, K., van den Berg, A., Pérez-Pomares, J. M., Segerink, L. I., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020214 · Cited by 26
“In order to fulfill this potential, it is imperative to develop assays that allow for robust and reproducible production as well as analysis of these cardiac tissues according to good manufacturing practices [29].”
BackgroundMethodPetersen, E. J., Sharma, M., Clippinger, A. J., Gordon, J., Katz, A., Laux, P., Leibrock, L., Luch, A., Matheson, J. M., Stucki, A., et al. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00080 · Cited by 27
iPS, organoids and 3D models as advanced tools for in vitro toxicology
Steimberg, N., Bertero, A., Chiono, V., Dell'Era, P., Angelantonio, S. D., Hartung, T., Perego, S., Raimondi, M. T., Xinaris, C., Caloni, F., et al. (2020) · ALTEX · doi:10.14573/altex.1911071 · Cited by 22
“It has been applied to study developmental neurotoxicity (Pamies et al., 2018) and is considered a promising tool for the study of neurodegenerative diseases (e.g., Parkinson’s, ALS), infectious diseases (e.g., Zika, JC, Dengue) and for gene/environment interactions.”
BackgroundMethodTowards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding
Humbert, M. V., Spalluto, C. M., Bell, J., Blume, C., Conforti, F., Davies, E. R., Dean, L. S. N., Elkington, P. T., Haitchi, H. M., Jackson, C. L., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00455-2022 · Cited by 21
Academic application of Good Cell Culture Practice for induced pluripotent stem cells
Tigges, J. (2021) · ALTEX · doi:10.14573/altex.2101221 · Cited by 19
“…there is guidance available for Good In Vitro Methods Practices in general (OECD, 2018) or stem cell-based Good Cell Culture Practice specifically (Pamies et al., 2017, 2018, 2020), giving detailed insights into the broad subject of quality assurance (QA) and quality control (QC) of in vitro…”
BackgroundSingh, P., Chandrasekaran, V., Hardy, B. J., Wilmes, A., Jennings, P., & Exner, T. E. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105229 · Cited by 20
Menoci: lightweight extensible web portal enhancing data management for biomedical research projects
Suhr, M., Lehmann, C. U., Bauer, C. R., Bender, T., Knopp, C. M., Freckmann, L., Hansen, B. Ö., Henke, C., Aschenbrandt, G., Kühlborn, L. K., et al. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03928-1 · Cited by 19
Organotypic Models to Study Human Glioblastoma: Studying the Beast in Its Ecosystem
Pamies, D., Zurich, M., & Härtung, T. (2020) · iScience · doi:10.1016/j.isci.2020.101633 · Cited by 19
Self-citationChemical concentrations in cell culture compartments (C5) – free concentrations
Kisitu, J. (2020) · ALTEX · doi:10.14573/altex.2008251 · Cited by 15
“This is particularly relevant for organoids and microphysiological systems (Alépée et al., 2014; Gordon et al., 2015; Marx et al., 2016, 2020; Pamies et al., 2017, 2018; Groothuis et al., 2015; Kramer et al., 2015; Punt et al., 2020).”
BackgroundLithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells
Fernandes, M. S., Barbisan, F., Azzolin, V. F., do Prado‐Lima, P. A. S., Teixeira, C. F., Jung, I. E. D. C., Assmann, C. E., Riffel, R. T., Duarte, M. M. M. F., Ribeiro, E. M. A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209223 · Cited by 18
Advanced Biomanufacturing Technologies for Micro-physiological Systems
Kim, M. K., Yoon, J., Kim, D., Kim, J., Kim, J.-S., Go, G., Song, J., Son, S., Park, K., Lee, J., et al. (2025) · International Journal of Precision Engineering and Manufacturing · doi:10.1007/s12541-025-01330-6 · Cited by 16
Pluripotent and Multipotent Stem Cells and Current Therapeutic Applications: Review
Worku, M. G. (2021) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s304887 · Cited by 16
Kuligovski, C., Robert, A. W., de Azeredo, C. M. O., Setti, J. A. P., & de Aguiar, A. M. (2021) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-75years-2021200723 · Cited by 36
Proteome Profiling of PMJ2-R and Primary Peritoneal Macrophages
Rusanov, A. L., Kozhin, P. M., Tikhonova, O. V., Zgoda, V. G., Loginov, D. S., Chlastáková, A., Selinger, M., Štěrba, J., Grubhoffer, L., & Luzgina, N. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126323 · Cited by 15
“Primary cells accurately model our cell type of interest’s behavior, as their structural and functional characteristics in vitro almost completely match those of the cells in vivo [1].”
BackgroundMuthu, S., Kartheek, R. R., Jeyaraman, N., Rajendran, R. L., Khanna, M., Jeyaraman, M., Packkyarathinam, R. P., Gangadaran, P., & Ahn, B. (2021) · Bioengineering · doi:10.3390/bioengineering8120220 · Cited by 15
Are hydroxyapatite-based biomaterials free of genotoxicity? A systematic review
de Souza, A. M., Dantas, M. R. D. N., Secundo, E. L., Silva, E. D. C., Silva, P. F., Moreira, S. M. G., & de Medeiros, S. R. B. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.141383 · Cited by 14
Celardo, I., Aschner, M., Ashton, R. S., Carstens, K. E., Cediel-Ulloa, A., Cöllen, E., Crofton, K. M., Debad, S. J., Dreser, N., Fitzpatrick, S., et al. (2025) · ALTEX · doi:10.14573/altex.2503191 · Cited by 18
“…building blocks are the exposure scheme, the test endpoint(s), the data-interpretation procedure (e.g., prediction model), the test system (e.g., selected cell type), and a defined purpose (Aschner et al., 2017; Bal-Price et al., 2018; Pamies et al., 2018; Holzer et al., 2023; Cöllen et al., 2024).”
Advanced Non-animal Models in Biomedical Research: Respiratory Tract Diseases
Jarlath, H., Lindsay, M., Adcock, I. M., Tomas, N., Nič, M., Dibusz, K., Gribaldo, L., & Maurice, W. (2020) · Joint Research Centre (European Commission) · doi:10.2760/725821 · Cited by 15
Animal Model Alternatives in Filovirus and Bornavirus Research
Widerspick, L., Steffen, J. F., Tappe, D., & Muñoz‐Fontela, C. (2023) · Viruses · doi:10.3390/v15010158 · Cited by 12
Suzuki, M., Baillo, A. A., Albarracín, L., Elean, M., Serda, R., Suda, Y., Namai, F., Nishiyama, K., Kitazawa, H., & Villena, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062688 · Cited by 11
“The use of cell lines avoids the limitations of individual variations observed in primary cultures and the phenotype changes through different passages [24].”
Gan, J., Bolon, B. N., Vleet, T. V., & Wood, C. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00005-4 · Cited by 15
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10
Self-citationBridging imaging-based in vitro methods from biomedical research to regulatory toxicology
Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., et al. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03922-z · Cited by 9
“…Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
Mommaerts, K., Bellora, C., Lambert, P., Türkmen, S., Schwamborn, J. C., & Betsou, F. (2021) · Biopreservation and Biobanking · doi:10.1089/bio.2020.0159 · Cited by 9
“30 In our study, primary cell culture of fibroblasts was initiated from 12 skin biopsies, excised from one skin surgical abdomi-noplasty, to eliminate potential bias resulting from genetic variations between different individuals.”
Daskalova, A., Angelova, L., Trifonov, A. A., Lasgorceix, M., Hocquet, S., Minne, M., Declercq, H., Leriche, A., Aceti, D. M., & Buchvarov, I. (2021) · Applied Sciences · doi:10.3390/app11062565 · Cited by 8
Datla, L. S. (2022) · International Journal of Emerging Research in Engineering and Technology · doi:10.63282/3050-922x.ijeret-v3i3p105 · Cited by 8
Influenza Virus Infections in Polarized Cells
Praena, B., & Wan, X. (2022) · Viruses · doi:10.3390/v14061307 · Cited by 10
Katz, L., Woolman, M., Tata, A., & Zarrine‐Afsar, A. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-03054-0 · Cited by 8
Bonaccorsi, S. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00461 · Cited by 10
Zang, R., Xin, X., Zhang, F., Li, D., & Yang, S. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26977 · Cited by 7
Baraka, S., Sam, A., Krysmann, M. J., Cook, N., Ahmed, W., & Barrak, F. (2025) · BDJ Open · doi:10.1038/s41405-025-00293-0 · Cited by 7
Pereira, M. G., de Almeida, O. G. G., da Silva, H. R. A., Ishizawa, M. H., & Martinis, E. C. P. D. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-02996-6 · Cited by 7
A New Predictive Technology for Perinatal Stem Cell Isolation Suited for Cell Therapy Approaches
Zia, S., Martini, G., Pizzuti, V., Maggio, A., Simonazzi, G., Reschiglian, P., Bonsi, L., Alviano, F., Roda, B., & Zattoni, A. (2021) · Micromachines · doi:10.3390/mi12070782 · Cited by 8
Engineered in vitro models: mimicking in vivo physiology
Shah, L., & Tirella, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823966-7.00002-5 · Cited by 5
Quality Control of Cell Lines Using DNA as Target
Carrillo-Ávila, J. A., Catalina, P., & Aguilar‐Quesada, R. (2022) · DNA · doi:10.3390/dna2010004 · Cited by 5
“Accordingly, GCCP is periodically revised to incorporate new cell technologies and approaches [9].”
BackgroundZell- und Gewebekultur: Allgemeine Grundlagen und spezielle Anwendungen
Gstraunthaler, G., & Lindl, T. (2021) · Springer eBooks · doi:10.1007/978-3-662-62606-1 · Cited by 9
Intestinal Organoids in Colitis Research: Focusing on Variability and Cryopreservation
Brügge, T. F. Z., Liese, A., Donath, S., Kalies, S., Kosanke, M., Dittrich‐Breiholz, O., Czech, S., Bauer, V. N., Bleich, A., & Büettner, M. (2021) · Stem Cells International · doi:10.1155/2021/9041423 · Cited by 5
“[22], who state that standardizing organoids is highly demanding due to their complexity, which “can be associated with variability between individual [.”
BackgroundFreudenrich, T. M., & Shafer, T. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813602-7.00033-8 · Cited by 6
Organoid models: Regulations and prospects for the development of investigational new drugs
Li, H., Pan, Y., Zheng, Z., Lin, R., Pan, Y., Lin, L., Quan, M., Lu, H., Hu, Z., Zheng, M., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004067 · Cited by 4
“[114,115] National Medical Products Administration (NMPA) China’s NMPA has stated that organoids can be considered for drug registration reviews, although the replacement of animal tests with organoids is evaluated on a case-by-case basis.”
Metabolomics applied to cultured human and animal cells
Artati, A., & Tokarz, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-812784-1.00008-6 · Cited by 4
Karreman, C., Kranaster, P., & Leist, M. (2019) · ALTEX · doi:10.14573/altex.1906251 · Cited by 4
Prakash, A., Malviya, R., Sridhar, S. B., Othman, R. Q. A., Agarwal, A., Wadhwa, T., & SHAREEF, J. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04848-8 · Cited by 4
The Center for Alternatives to Animal Testing in the USA and Europe
Goldberg, A. M., Leist, M., & Härtung, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813697-3.00014-7 · Cited by 3
Application of the 3Rs principles in the development of pharmaceutical generics
Vichare, A. S., Kamath, S. U., Leist, M., Hayes, A. W., & Mahadevan, B. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105016 · Cited by 4
Alternative methods to animal experimentation for testing developmental toxicity
Pamies, D., Estevan, C., Vilanova, E., & Sogorb, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00007-2 · Cited by 3
Self-citationWellens, S., Gosselet, F., & Culot, M. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105424 · Cited by 3
Metadata
- Authors
- Pamies, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pamies, David
- ORCID
- Pamies, David
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 3
- Pages
- 353-378
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2799414163
- Cited by
- 127
- References
- 140
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 26 · 2019: 15 · 2018: 4
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- University of Twente Research Information (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Joint Research Centre (European Commission) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Horizon 2020 Framework Programme (EU‐H2020, 681002)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- replication crisis, induced pluripotent stem cells, organoids, organ-on-a-chip, primary human cells, cell banks, high-content imaging, high-throughput measurement
- MeSH terms
- Animals, Animal Testing Alternatives, Education, Germany, Humans, Organoids, Quality Control, Guidelines as Topic, Cell Culture Techniques, Pluripotent Stem Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



